Intercept Pharmaceuticals Investor Relations Material
Latest events
Q2 2023
Intercept Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Intercept Pharmaceuticals Inc
Access all reports
Intercept Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for chronic liver diseases. The company’s research includes treatments for conditions such as primary biliary cholangitis and nonalcoholic steatohepatitis. Intercept Pharmaceuticals Inc is headquartered in Morristown, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
ICPT
Country
🇺🇸 United States